Literature DB >> 12745360

The monitoring of drug trends in Australia.

Fiona Shand1, Libby Topp, Shane Darke, Toni Makkai, Paul Griffiths.   

Abstract

Recently, there has been increased recognition of the importance of drug information systems (DIS), highlighting the need for an internationally coordinated approach to data collection and advocating the regular assessment of a range of areas. Accurate information provides policy makers with the evidence to evaluate current strategies and to plan future strategies. An effective drug information system (DIS) must collect comprehensive, detailed and in-depth data, while also being sensitive to emergent trends and placing these changes into the context of longer-term trends. An integrated and comprehensive system combines both sensitive (or lead) and slower but more reliable lag indicators. This article reviews conceptual frameworks for DIS and developments in international systems. It then considers the range of DIS in Australia and then describes two integrated monitoring systems with an early warning function: the Illicit Drug Reporting System (IDRS) and the Drug Use Monitoring Australia (DUMA) Programme. Both systems collate sensitive lead indicators, and provide timely information about emerging drug trends in Australia. Together, these two systems are best-placed to provide effective early warning of new trends in illicit drug markets, and constitute an important component of the overall approach to the monitoring of drug use and associated harms in Australia.

Mesh:

Year:  2003        PMID: 12745360     DOI: 10.1080/0959523021000059848

Source DB:  PubMed          Journal:  Drug Alcohol Rev        ISSN: 0959-5236


  2 in total

1.  Drug, sex and age differentials in the use of Australian publicly funded treatment services.

Authors:  Jane Anne Fischer; Alexandra Marie Clavarino; Jackob Moses Najman
Journal:  Subst Abuse       Date:  2012-03-07

2.  People who inject drugs (PWID) and HIV/aids cases in Mexico City: 1987-2015.

Authors:  Martha Romero Mendoza; Denize Meza-Mercado; Rosario Martínez-Martínez; Carlos Magis-Rodríguez; Arturo Ortiz Castro; Maria Elena Medina-Mora
Journal:  Subst Abuse Treat Prev Policy       Date:  2019-12-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.